This is a prospective, international multi-center, open-labeled, randomized trial.
The investigator speculated that CNA prevents more patients with moderate to severe VVS from
syncope recurrence compared to midodrine.
Phase:
N/A
Details
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborators:
Beijing Chao Yang Hospital First Affiliated Hospital Xi'an Jiaotong University First Affiliated Hospital, Sun Yat-Sen University Fuwai Yunnan Cardiovascular Hospital Henan Provincial People's Hospital Ningbo No. 1 Hospital RenJi Hospital Yeditepe University Hospital